ロード中...
Response to Combined Molecular Targeting: Defining the Role of P-STAT3
Src family kinase- (SFK-) targeting agents are currently undergoing clinical investigation for treatment of solid malignancies. EGFR-independent phosphorylation of STAT3 (P-STAT3) has been identified as a mechanism of tumor resistance to agents targeting SFK. Tumor P-STAT3 levels may be an important...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3149866/ https://ncbi.nlm.nih.gov/pubmed/21266530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2925 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|